These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 20800825)

  • 41. Molecular mechanisms underlying the regulation and functional plasticity of FOXP3(+) regulatory T cells.
    Gao Y; Lin F; Su J; Gao Z; Li Y; Yang J; Deng Z; Liu B; Tsun A; Li B
    Genes Immun; 2012 Jan; 13(1):1-13. PubMed ID: 22048454
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stability of regulatory T-cell lineage.
    Hori S
    Adv Immunol; 2011; 112():1-24. PubMed ID: 22118405
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulatory T cell plasticity: beyond the controversies.
    Hori S
    Trends Immunol; 2011 Jul; 32(7):295-300. PubMed ID: 21636323
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thymic and peripheral differentiation of regulatory T cells.
    Lee HM; Bautista JL; Hsieh CS
    Adv Immunol; 2011; 112():25-71. PubMed ID: 22118406
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dominant Th2 differentiation of human regulatory T cells upon loss of FOXP3 expression.
    Hansmann L; Schmidl C; Kett J; Steger L; Andreesen R; Hoffmann P; Rehli M; Edinger M
    J Immunol; 2012 Feb; 188(3):1275-82. PubMed ID: 22210907
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of regulatory T cells: epigenetics and plasticity.
    Okada M; Hibino S; Someya K; Yoshmura A
    Adv Immunol; 2014; 124():249-73. PubMed ID: 25175778
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Suppression assays with human T regulatory cells: a technical guide.
    McMurchy AN; Levings MK
    Eur J Immunol; 2012 Jan; 42(1):27-34. PubMed ID: 22161814
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epigenetic and transcriptional control of Foxp3+ regulatory T cells.
    Huehn J; Beyer M
    Semin Immunol; 2015 Feb; 27(1):10-8. PubMed ID: 25801206
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adenosine A2B receptor antagonist suppresses differentiation to regulatory T cells without suppressing activation of T cells.
    Nakatsukasa H; Tsukimoto M; Harada H; Kojima S
    Biochem Biophys Res Commun; 2011 May; 409(1):114-9. PubMed ID: 21557932
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessing the suppressive activity of Foxp3⁺ regulatory T cells.
    Mayer CT; Sparwasser T
    Methods Mol Biol; 2014; 1193():85-96. PubMed ID: 25150999
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lineage stability and phenotypic plasticity of Foxp3⁺ regulatory T cells.
    Hori S
    Immunol Rev; 2014 May; 259(1):159-72. PubMed ID: 24712465
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Two modes of immune suppression by Foxp3(+) regulatory T cells under inflammatory or non-inflammatory conditions.
    Yamaguchi T; Wing JB; Sakaguchi S
    Semin Immunol; 2011 Dec; 23(6):424-30. PubMed ID: 22055883
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Functional dynamics of Foxp3⁺ regulatory T cells in mice and humans.
    Bin Dhuban K; Kornete M; S Mason E; Piccirillo CA
    Immunol Rev; 2014 May; 259(1):140-58. PubMed ID: 24712464
    [TBL] [Abstract][Full Text] [Related]  

  • 54. FoxP3, Helios, and SATB1: roles and relationships in regulatory T cells.
    Grzanka J; Leveson-Gower D; Golab K; Wang XJ; Marek-Trzonkowska N; Krzystyniak A; Wardowska A; Mills JM; Trzonkowski P; Witkowski P
    Int Immunopharmacol; 2013 Jul; 16(3):343-7. PubMed ID: 23428911
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells.
    Kryczek I; Wei S; Zou L; Zhu G; Mottram P; Xu H; Chen L; Zou W
    J Immunol; 2006 Jul; 177(1):40-4. PubMed ID: 16785496
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity.
    Luo CT; Liao W; Dadi S; Toure A; Li MO
    Nature; 2016 Jan; 529(7587):532-6. PubMed ID: 26789248
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tolerogenic vaccines: Targeting the antigenic and cytokine niches of FOXP3
    Mannie MD; DeOca KB; Bastian AG; Moorman CD
    Cell Immunol; 2020 Sep; 355():104173. PubMed ID: 32712270
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differentiation and function of Foxp3(+) effector regulatory T cells.
    Cretney E; Kallies A; Nutt SL
    Trends Immunol; 2013 Feb; 34(2):74-80. PubMed ID: 23219401
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulatory T cell identity: formation and maintenance.
    Li X; Zheng Y
    Trends Immunol; 2015 Jun; 36(6):344-53. PubMed ID: 25981968
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The transcription factor Batf3 inhibits the differentiation of regulatory T cells in the periphery.
    Lee W; Kim HS; Hwang SS; Lee GR
    Exp Mol Med; 2017 Nov; 49(11):e393. PubMed ID: 29147008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.